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Localization ofthe Gene for MEN 2 A

Jay B. Lichter,* Michael Difihppantonio,* Jingshi W u / Diane Miller,* David C. Ward,*
Paul J. Goodfellow, • and Kenneth K. Kidd*

The search for the gene that causes the multiple endocrine neoplasia type 2 A (MEN 2 A) syndrome is
entering a new phase. Genetic linkage studies have localized the gene to the pericentromeric region of
chromosome 10. The statistical portion of mapping the gene for MEN 2A is nearly complete and now
classical molecular biological/gene mapping techniques will be employed. We have used fluorescence in situ hybridization to estimate the size ofthe MEN2A region to be ahout 2 to 5 mb, using some
liberal assumptions; at worst the region should contain no more than about 10 mb of non-alphoid
DNA. Our mapping panels (meiotic recombinant and radiation reduced hybrid) give consistent
orders of markers in this small region. We describe our initial attempts to clone the region using yeast
artificial chromosomes. (Henry Ford Hosp Med J 1992:40:199-204]

T

he positional cloning approach has been extremely successful in recent years in identifying and cloning several genes
causing inherited disorders. In such studies genetic linkage provides the initial regional position of the disease gene, followed
by molecular work to identify and clone the specific gene.
Duchenne muscular dystrophy was an early success aided by
numerous deletion mutants (1); cystic fibrosis was another success aided by linkage disequilibrium and a biochemical defect in
a specific tissue (2-4); and polyposis coli is a recent success
aided by a rare deletion mutant (5,6). The hope/expectation is
that multiple endocrine neoplasia type 2A (MEN 2A) will soon
join this list of success stories, but there are also cautionary
notes sounded by the difficuhies in identifying and cloning the
gene for Huntington disease (7,8), since deletions have not been
found and linkage disequilibrium does not provide much help in
localization. The work on MEN 2A is now focused largely on
molecular efforts to localize and clone the gene; that search is
concentrated in a small region of chromosome 10 that has been
defined by the genetic linkage studies that have been done over
the last decade. We wish to review briefiy those initial studies
that localized MEN2A to the pericentromeric region of chromosome 10 as an introduction to our current efforts to narrow the
region even further, clone the region, and identify the gene.

Regional Localization of MEN2A
At the first MEN 2A workshop in Kingston, Ontario, the initial linkage .studies with DNA markers were presented (9) but
littie of the genome had been studied, much less excluded. The
initial positive linkage findings for MEN 2A occurred at the second workshop with the chromosome 10 marker D10S5; by that
time, one-third of the genome had been excluded (10). The initial LOD score was not significant (less than 3) but more extensive typing confirmed the positive finding. A second marker.
RBP3, documented to be near the centromere of chromosome
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10, was fortuitously closer to the MEN2A locus, allowing conclusive evidence for the location of MEN2A near the centromere of chromosome 10(11,12). Initially, there was no linkage
map for chromosome 10 and few markers. The demonstration
that RBP3 was linked to MEN2A and to D10S5 constituted the
first map of part of chromosome 10. Our progressive building of
the chromosome 10 linkage map since these initial findings is illustrated in Fig 1.
Initially, the orientation of RBP3 and D10S5 (and hence the
orientation of MEN2A) along the chromosome was unknown
but the order became clear when we mapped three markers,
D10S3, DlOSl, and D10S4, distal to D10S5 (13). We subsequently added four other markers to the linkage map of chromosome 10: D10S20 (14), D10S24 (15), the OAT locus (16), and
EGR2 (17). Others were also working on mapping chromosome
10(18-20) and in 1990 the first CEPH consortium map was published (21). That map, however, had no markers closer to
MEN2A than RBP3. At the same time, several polymorphisms
were identified for a clone for the beta subunit of the human fibronectin receptor, FNRB (22), and the FNRB locus became our
closest fianking short arm marker, about the same distance from
MEN2A that RBP3 was. Another short arm marker, D10S34,
had been characterized by Nakamura et al (19). This marker also
appeared to be roughly the same distance away from RBP3 as
FNRB and, therefore, a close fianking marker on the short arm
of chromosome 10. We identified several new polymorphisms
closer to MEN2A at the centromeric alpha satellite locus D1 OZ 1
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Fig I—Progressive building ofthe chromosome 10 linkage map. Vertical lines are roughly proportional representations ofthe linkage maps. Horizontal lines mark the position ofthe loci in the map. The MEN2A region is labeled. The arrow at the botlom shows the
rough time scale.
of chromosome 10 (23,24). We showed MEN2A to be completely linked to DlOZl in our sample and definitely flanked by
FNRB on the proximal short arm and RBP3 on the proximal
long arm (25,26).
These markers now make DNA-based diagnosis feasible.
Data on FNRB, RBP3, and DIOS 15 allowed us to obtain probabilities greater than 95% for diagnosis in 77% of patients and
probabilities greater than 90% for a diagnosis in 90% of patients
(27). This study showed that difficuhies in the clinical diagnostic criteria for MEN 2A lead to difficulties in the genetic diagnoses: we feel that C-cell hyperplasia alone, in the absence of a
clear breach of the basal membrane, is not sufficient to conclude
that a patient has MEN 2A (27).
The position of the short arm marker D10S34 with respect to
FNRB has not previously been determined. Our recent analysis
(27A) shows D10S34 is proximal to FNRB. The LOD scores between FNRB and D10S34 are a maximum at 8,^^, = 2.4%, LOD
= 34.19, with no significant sex difference observed in our data.
We have found four meiotic recombination events between
FNRB and D10S34 that support the order of FNRB, D10S34,
DlOZl. This order is in agreement with preliminary data from
other groups (28) and shows that D10S34 is about 2.4 cM closer
to DlOZl than FNRB, making D10S34 our most proximal polymorphic short arm marker definitelyfiankingMEN2A.

Fine Structure Linkage Mapping of the Region
The same logic of identifying crossovers to order markers
has been applied to MEN2A. We have identified seven crossovers between MEN2A and various nearby markers. One of
those crossovers is one of the four mentioned above that occurs
between D10S34 and FNRB. This panel of seven meioses will
continue to be instmmental in locating the gene to the smallest
possible region of DNA that cosegregates with the disease.
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greatly reducing the molecular size of the region from the full
D10S34-RBP3 interval currently being studied. (The one confirmed crossover between DlOZl and MEN2B [29,30] already
narrows the region to the proximal long arm if we assume MEN
2 A is caused by the same locus as MEN 2B or another extremely
close one; while plausible, it is presently merely an assumption.)
In a similar fashion, we have identified several recombinant
chromosomes that are not informative for MEN2A. These come
from unaffected individuals in both MEN 2A kindreds and in
other non-MEN 2A kindreds. These crossovers allow us to use a
larger meiotic mapping panel for ordering markers in this region. A subset of these crossovers was used to determine the order of FNRB and D10S34. We have refined the positions of 36
crossovers in our family material and there are additional crossovers in the CEPH families that we have not yet studied. Our
crossovers divide the region from FNRB to D IOS 15 into 37 regions for high resolution meiotic mapping.
Three markers that have so far not been seen to be separated
from MEN2A by crossovers have been mapped using the meiotic mapping panel (27A). Each of these markers (D10S94,
D10S97, D1 OS 102) has already been shown to map into the region between DlOZl and RBP3 (31-33); however, the relative
order of these loci was not known. Data from the meiotic mapping panel suggest the order of these loci to be (DlOZl,
D10S94)-D10S97-D10S102-RBP3. Each interval is defined by
at least two crossovers except the D10Z1,D10S94 interval, in
which no recombinants have been detected. Although every effort is made to insure that the typing data are free of errors, errors
cannot be absolutely ruled out for any particular crossover.
Moreover, some "crossovers" represent only the most likely interpretation of the data; other interpretations may be possible.
Thus, until this order can be confirmed either by a large number
of crossovers or by physical cloning, we consider this order the
most likely but not the definitive ordering.

Ijjcalization ofthe Gene for MEN 2A—Lichter et al

More Polymorphisms
The meiotic mapping panel is only as valuable as the number
of informative polymorphic loci that have been mapped in it.
We would ultimately like to have at least one locus in each of the
37 intervals from FNRB to DIOS 15. However, an immediate
goal is to make the 20 crossovers that are definitely between
D10S34 and RBP3 fully informative for a series of loci that wUl
be spaced at about 1 mb intervals. Several new clones are being
typed by standard restriction fragment length polymorphism
technology for segregation in these meiotic mapping panels.
However, this technology may be limited in the extent of informativeness ofany given locus.
Several new techniques based on the polymerase chain reaction (PCR) (33,34) are capable of detecting more informative
polymorphisms. The short tandem repeats (STR) or microsatellites (35) are blocks of di-, tri-, or tetranucleotides (sometimes
more) with the most common being repeating dinucleotides. Estimates of the number of STR loci in human DNA range from
about 35,000 to 130,000 (36) for CA repeats alone and Edwards
and associates (37) estimate a like number for the total of the
various tri- and tetranucleotides. making STRs one of the most
abundant sources of polymorphisms. With over 200 of these repeats having already been identified as being polymorphic, it is
rapidly becoming possible to efficiently scan the genome as
well as chromosome 10 using these markers (35).
Both single stranded conformational polymorphisms (SSCP)
and denaturing gradient gel electrophoresis (DGGE) are extremely sensitive in detecting polymorphisms in the genome,
but because of the technical difficulty of these techniques, it is
not generally practical to use them to generate LOD scores from
several hundred individuals. Furthermore, our interest now is
making each recombination event fully intbrmative for evenly
spaced loci, so a complete statistical analysis is unnecessary.
The use of SSCP and DGGE on the donors of recombinant chromosomes is quite feasible. We have developed a way to streamline this technique further. We have developed "family" tubes to
rapidly test our meiotic panel for informativeness of particular
PCR products using DGGE. Each tube contains pooled DNA
from five individuals who are meiotic recombinant donors; we
amplify the pooled DNA for a segment of DNA within the region of interest. The resulting product is subjected to DGGE.
We can detect most DNA variation in this fashion and will be
able to scan the entire meiotic panel on one single gel. The sensitivity ofthis technique has been fully explored and the approach
used succes.sfully in our population studies (unpublished data).
Our studies in the meiotic mapping panel have so far not yielded
any new polymorphisms but large amounts of newly cloned material and DNA sequence are just becoming available, as yeast
artificial chromosome (YAC) cloning gains momentum.

Other Methods Used to Order
Markers into a Region
As mentioned above, the statistical portion of the linkage
phase of mapping MEN2A is reaching its limits. Current focus
is on the refinement of the linkage map and detecting and mapping crossovers. Although we are continuing to exploit the mei-
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Fig 2—Cytogenetic limits ofthe MEN2A region. FLpter % is the
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otic mapping panel, the majority of current work involves the
molecular characterization and actual cloning of the region.
While the meiotic mapping panel will continue to be a valuable
and powerful tool for ordering clones from the region, other,
more molecular mapping techniques will also be invaluable in
the search for MEN2A by independently confirming the order of
loci mapped using the meiotic mapping panel.
Fluorescence in situ hybridization
Fluorescence in situ hybridization (FISH), as the name suggests, utilizesfiuorescent-labeledDNA molecules as hybridization probes on human metaphase chromosomes (38). This technique is rapid and highly specitic. The positions of probes along
the chromosome are measured as the fractional length of the
chromosome from the tip of the short arm. Although the resolution ofthis technique is limited to about 1 mb, it can be useful to
determine whether a new marker falls into the region of interest.
We have mapped 37 chromosome 10 clones using FISH on
metaphase spreads. Several of these clones are "anchor" markers that are also in the linkage map (39), but most of these probes
are new clones. We have found three new clones that map in the
pericentromeric region using this technique.
We are using our FISH results for the fianking markers
D10S34 and RBP3 to estimate the amount of DNA in the
MEN2A region. Our current estimation for the maximum size of
the region is 17% of chromosome 10 using the most distal FISH
locations for D10S34 and RBP3 (Fig 2) on metaphase chromosomes. Chromosome 10 has been estimated to contain 4.4% of
total genomic DNA. If we assume that mitotic chromosome
length is proportional to the length of DNA, this region contains
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about 22 mb of DNA (3 x 10"* x 4,4% x 17% = 2.2 x 10^ base
pairs). We believe we can use additional clones in combination
with our MEN2A meiotic mapping panel to reduce the region
cosegregating with MEN2A to less than 10% of the entire chromosome. (Assuming a random, uniform distribution of crossovers in the region, this is a conservative estimate. However, our
data suggest crossovers occur more frequently as one moves
away from the centromere and closer to DIOS34 or to RBP3.)
Thus, the meiotically defined MEN2A region will be about 10
to 15 mb of DNA (3 x 10'' x 4.4% x 10% =13x10*^ base pairs).
Ofthis, 2 to 5 mb will be alpha satellite sequences (40). Therefore, we expect the entire region cosegregating with MEN2A to
be not more than 10 mb of nonalphoid DNA. If we further assume that MEN2A is on the proximal long arm of chromosome
10 using the MEN2B crossover data (29,30), then the region is
only about 5% of chromosome 10 or about 2 to 5 mb of DNA.
This estimate of the cytogenetic limits of the MEN2A region
suggests that the region is now small enough to consider complete cloning.

Radiation reduced hybrid mapping
Another approach to mapping and ordering probes in a small
region is the use of radiation reduced hybrids. These hybrid cell
lines are developed by radiation treatment of somatic cell hybrid
lines in which the chromosome of interest is the only human material, in this case human chromosome 10. The hybrids are
scored by Southem blot hybridization of chromosome specific
probes or by PCR using specific primers. A positive hybridization signal or a PCR product of the right size and sequence indicates that a hybrid line contains that target sequence. These hybrid lines tend to accumulate complex rearrangements and deletions that can make interpretations difficult. One can use either a
least number of breaks hypothesis or a likelihood analysis to
make a radiation hybrid panel powerful for ordering probes
(41).
We have recently used a radiation reduced hybrid panel with
several of our chromosome 10 probes (41 A). The order of
probes that we have determined for the pericentromeric region
of chromosome 10 using the radiation reduced hybrid panel
agrees with the order determined by the meiotic mapping panel:
D1 OZ 1-D10S94-D10S97-D1 OS 102-RBP3 (41 A). These two independent methods for determining the order of loci complement each other to help refine the map of the entire region. However, neither method is infallible. The radiation hybrid and the
meiotic mapping techniques both rely on determining the most
likely map based on the data. The most likely map might not be
the actual map.

Contig mapping—cloning the region
The ultimate test of order is the complete cloning of the part
of the region from D10S34 to RBP3 that cosegregates with
MEN2A. Once the region is completely cloned with an ordered
set of overlapping clones, each "new" clone can be precisely
mapped with the "exact" number of base pairs known between
several loci. Given the currently estimated size of the region as
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10 to 15 mb (including the centromere), standard plasmid,
phage, or cosmid clones would not be an efficient means of
cloning the region. To cover 2 to 5 mb with cosmids, with an average insert size of 35 kb, would take a minimum of 150 clones
if they were minimally overlapping; in reality at least 500 clones
would have to be studied.
YACs offer an excellent source of clones with large inserts.
We have begun a YAC screening effort with the CEPH YAC l i brary (42). An average YAC in this library contains human
DNA inserts of about 400 kb. Using this size insert reduces the
number of independent clones needed to cover the entire region
by a factor of about 10 relative to cosmids. Fifteen to 50 clones
is more feasible than 150 to 500. We are using a PCR-based
.screening approach using sequence-tagged sites for clones that
we have isolated and mapped to the region. We hope to be able
to establish that the region is only about 2 to 5 mb of DNA.
We first attempted to find YACs for the D10S97 locus
(32,43) using sequence for the clone KW6. That clone detects
two loci on chromosome 10 by FISH, and we believe that the
clone itself derives from the middle of the short arm (32). The
polymorphism, mapped by the linkage and radiation hybrid
panels, exists in 1 Oqi 1.2 sequences recognized by cross hybridization. We have found three YACs for the probe KW6 (CEPH
YAC numbers 27B11, 185E2, and 261B8). Unfortunately, but
not unexpectedly, these YACs map by FISH to the lOp locus
(D10F38S2) that is detected by the probe KW6 (32,43). These
YACs, although not in the region, show that the PCR-based
screening method for the YAC library is feasible. Though KW6
is a known special case of "duplicated" segments of homologous sequences, the result illustrates the need to confirm that
YACs map into the region and are not isolated because of some
shared homologous sequence elsewhere in the genome. We are
now working to identify YACs at D10S94.

Cloning the MEN2A Gene
The ultimate question is how will the gene for MEN2A actually be cloned? The cloning and mapping of the entire region
will be relatively easy, compared to the task of actually finding
the gene. Small deletions or rearrangements in the DNA of affected individuals will point towards candidate regions. Linkage
disequilibrium may be helpful in identifying a candidate region.
However, except within families, linkage disequilibrium wdl
only exist if there were relatively few MEN2A mutations. In the
absence of either of these guides, systematic testing ofeach gene
in the region for point mutations is the only current recourse.
The now "classical" approach of positional cloning has been
successful in the cloning of several disease-causing genes
(4,6,44). We expect that this strategy will also lead to the identification of the gene responsible for MEN2A.

Summary
We now have excellent tools for the mapping and cloning of
the MEN2A region. The mapping tools have their individual
strengths and serve as cross-checks for each other. Furthermore,
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we have the means necessary to clone the region using YACs
derived from the CEPH YAC library. Complete cloning of the
region will provide the DNA in which other techniques can be
used to identify the gene responsible for MEN 2A. In the meantime, a by-product of this work will be new, highly informative
markers that will not only help the re.search by refining the limits
ofthe relevant region using the mapping panels but also increase
the diagnostic capabilities of the DNA-based tests.
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